Charles River Laboratories (CRL) Tops Q1 EPS by 8c; Boosts Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St mixed as benchmark Treasury yields reach 5%, oil takes a pause
- Oil slides following outreach to Iran to limit Houthis actions in Red Sea
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Charles River Labs (CRL) Number Cut at Jefferies on Slower Start; 'Buy' Maintained
May 1, 2014 10:46 AM EDTJefferies analyst David Windley lowered estimates and his price target on Buy-rated Charles River Labs (NYSE: CRL) to $66.00 (from $73.00) following Q1 results which showed a slower start to the year.
Windley comments, "CRL's results met internal expectations, but they fell shy of ours.... More
